Global Companies May See Sharp Price Cuts As India Approves New Drug Pricing Policy
This article was originally published in PharmAsia News
Executive Summary
A committee of Indian cabinet ministers has agreed to determine drug pricing on a simple average of products sold in a particular therapy area. The decision will lead to lower drug prices but the industry is set to face tougher market competition.